Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19

Microbiology Spectrum(2025)10.1128/spectrum.01829-24Source: DataRank Database

The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19 is a research paper published in Microbiology Spectrum (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 3.98)OA: goldTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Eleanor G. Bentley ORCID,Parul Sharma ORCID,Adam Kirby ORCID,I’ah Donovan-Banfield ORCID,Anja Kipar ORCID

Live enrichment

PubMed:40130852 OpenAlex:https://openalex.org/W4408831444

Medical Research Council

Grant: MR/W005611/1, MR/Y004205/1, MR/R010145/1, MR/W021641/1, PA6162_G2P2-2023

U.S. Food and Drug Administration

Grant: 75F40120C00085

Wellcome Trust

Grant: 222489/Z/21/Z

Wellcome EPSRC Centre for Medical Engineering

Grant: EP/R024804/1, EP/S012265/1

National Institutes of Health

Grant: R01AI134091, R24AI118397

Biotechnology and Biological Sciences Research Council

Grant: BB/R00904X/1, BB/R018863/1, BB/N022505/1

Innovate UK

Grant: TS/W022648/1

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: IZSEZ0 213289

NIAID NIH HHS

Grant: R24 AI118397

NIAID NIH HHS

Grant: R01 AI134091

Wellcome Trust

FWCI

3.98

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by

journalhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01829-24?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01829-24?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01829-24

journalhttps://doi.org/10.1128/spectrum.01829-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40130852

Fields of Study

SARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAnimalsAntiviral AgentsBridged Bicyclo CompoundsCytidineDisease Models, AnimalFemaleHumansHydroxylaminesMorpholinesMutationUridineGenome, ViralImmunocompromised HostViral LoadMice

Keywords

ImmunosuppressionContext (archaeology)BiologyImmunologyViral loadVirologyMutationVirusCoronavirusCoronavirus disease 2019 (COVID-19)DiseaseGeneticsMedicineGeneInternal medicineInfectious disease (medical specialty)ImmunocompromisedIntra-host EvolutionCovid-19Sars-cov-2MolnupiravirPaxlovidNirmatrelvir

Sustainable Development Goals

SDG 0: Good health and well-being